The store will not work correctly when cookies are disabled.
4-(6-methyl-pyridazin-3-yl ethylene) N'-pyridin-2-yl thiosemicarbazone
ID: ALA113466
PubChem CID: 9579514
Max Phase: Preclinical
Molecular Formula: C14H16N6S
Molecular Weight: 300.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C/C(=N\N=C(/S)NCc1ccccn1)c1ccc(C)nn1
Standard InChI: InChI=1S/C14H16N6S/c1-10-6-7-13(19-17-10)11(2)18-20-14(21)16-9-12-5-3-4-8-15-12/h3-8H,9H2,1-2H3,(H2,16,20,21)/b18-11+
Standard InChI Key: FASJSAQXCLCYBA-WOJGMQOQSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
-0.1333 -0.8792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9500 -1.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9125 -1.4792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3875 -0.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9042 -0.8792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6500 -0.5792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4292 -1.7792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9500 -0.8792 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.4667 -1.7792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5042 -2.3750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3875 0.0208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6500 0.0208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5042 -1.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9875 -1.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1333 0.3208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4292 -0.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0292 -2.6750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1708 0.3208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0250 -1.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5500 -2.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5417 -1.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 7 2 0
3 5 2 0
4 1 2 0
5 4 1 0
6 1 1 0
7 3 1 0
8 2 1 0
9 2 1 0
10 13 2 0
11 4 1 0
12 6 2 0
13 14 1 0
14 9 1 0
15 12 1 0
16 5 1 0
17 10 1 0
18 12 1 0
19 13 1 0
20 21 1 0
21 19 2 0
15 11 2 0
20 17 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 300.39 | Molecular Weight (Monoisotopic): 300.1157 | AlogP: 1.98 | #Rotatable Bonds: 4 |
Polar Surface Area: 75.42 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 6.61 | CX Basic pKa: 3.44 | CX LogP: 0.80 | CX LogD: 0.10 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.39 | Np Likeness Score: -1.81 |
References
1. Easmon J, Heinisch G, Holzer W, Rosenwirth B.. (1992) Novel thiosemicarbazones derived from formyl- and acyldiazines: synthesis, effects on cell proliferation, and synergism with antiviral agents., 35 (17): [PMID:1354751] [10.1021/jm00095a027] |